The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease. (Q52757816)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28843411 AND SRC:MED&resulttype=core&format=json

28 March 2020

title

The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28843411 AND SRC:MED&resulttype=core&format=json

28 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28843411 AND SRC:MED&resulttype=core&format=json

28 March 2020

author name string

Toshifumi Sugatani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28843411 AND SRC:MED&resulttype=core&format=json

28 March 2020

Olga A Agapova

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28843411 AND SRC:MED&resulttype=core&format=json

28 March 2020

Yifu Fang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28843411 AND SRC:MED&resulttype=core&format=json

28 March 2020

Joseph P Gaut

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28843411 AND SRC:MED&resulttype=core&format=json

28 March 2020

Marie-Claude Faugere

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28843411 AND SRC:MED&resulttype=core&format=json

28 March 2020

Hartmut H Malluche

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28843411 AND SRC:MED&resulttype=core&format=json

28 March 2020

Keith A Hruska

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28843411 AND SRC:MED&resulttype=core&format=json

28 March 2020

language of work or name

English

0 references

publication date

23 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28843411 AND SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28843411 AND SRC:MED&resulttype=core&format=json

28 March 2020

volume

93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28843411 AND SRC:MED&resulttype=core&format=json

28 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28843411 AND SRC:MED&resulttype=core&format=json

28 March 2020

page(s)

147-158

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28843411 AND SRC:MED&resulttype=core&format=json

Human activin-A is expressed in the atherosclerotic lesion and promotes the contractile phenotype of smooth muscle cells

28 March 2020

cites work

1 reference

12 December 2020

X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males

1 reference

12 December 2020

Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction

1 reference

12 December 2020

Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation

1 reference

12 December 2020

Cholesterol in vascular and valvular calcification

1 reference

12 December 2020

Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease

1 reference

12 December 2020

Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy

1 reference

12 December 2020

Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures

1 reference

12 December 2020

Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function

1 reference

12 December 2020

COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome

1 reference

12 December 2020

Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification

1 reference

12 December 2020

Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome

1 reference

12 December 2020

BMP7 antagonizes TGF-beta -dependent fibrogenesis in mesangial cells

1 reference

12 December 2020

Activin A stimulates IkappaB-alpha/NFkappaB and RANK expression for osteoclast differentiation, but not AKT survival pathway in osteoclast precursors

1 reference

12 December 2020

Mouse model of X-linked Alport syndrome.

1 reference

12 December 2020

Pathophysiology of vascular calcification in chronic kidney disease

1 reference

12 December 2020

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

12 December 2020

Renal fibrosis: new insights into the pathogenesis and therapeutics

1 reference

12 December 2020

Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study

1 reference

12 December 2020

BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury

1 reference

12 December 2020

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

1 reference

12 December 2020

Control of bone mass and remodeling by PTH receptor signaling in osteocytes

1 reference

12 December 2020

TGF-beta signaling in vascular biology and dysfunction

1 reference

12 December 2020

Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries

1 reference

12 December 2020

The biology of activin: recent advances in structure, regulation and function

1 reference

12 December 2020

Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin

1 reference

12 December 2020

Activin signaling as an emerging target for therapeutic interventions

1 reference

12 December 2020

Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease

1 reference

12 December 2020

A soluble activin receptor Type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeys

1 reference

12 December 2020

Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome.

1 reference

12 December 2020

Vascular calcification in animal models of CKD: A review

1 reference

12 December 2020

Inhibiting activin-A signaling stimulates bone formation and prevents cancer-induced bone destruction in vivo

1 reference

12 December 2020

Klotho deficiency is an early biomarker of renal ischemia–reperfusion injury and its replacement is protective

1 reference

12 December 2020

Klotho deficiency causes vascular calcification in chronic kidney disease

1 reference

12 December 2020

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

1 reference

12 December 2020

Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease

1 reference

12 December 2020

Osteocyte RANKL: New insights into the control of bone remodeling

1 reference

12 December 2020

Transforming growth factor-β and smooth muscle differentiation

1 reference

12 December 2020

Alport syndrome--insights from basic and clinical research

1 reference

12 December 2020

Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy.

1 reference

12 December 2020

Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy

1 reference

12 December 2020

The ALK-1/Smad1 pathway in cardiovascular physiopathology. A new target for therapy?

1 reference

12 December 2020

Early chronic kidney disease-mineral bone disorder stimulates vascular calcification

1 reference

12 December 2020

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease

1 reference

12 December 2020

Translational profiles of medullary myofibroblasts during kidney fibrosis.

1 reference

12 December 2020

The kidney is the principal organ mediating klotho effects

1 reference

12 December 2020

Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl

1 reference

12 December 2020

Alport syndrome from bench to bedside: the potential of current treatment beyond RAAS blockade and the horizon of future therapies

1 reference

12 December 2020

BMP-9 regulates the osteoblastic differentiation and calcification of vascular smooth muscle cells through an ALK1 mediated pathway

1 reference

12 December 2020

Klotho and phosphate are modulators of pathologic uremic cardiac remodeling

1 reference

12 December 2020

Searching for a treatment for Alport syndrome using mouse models

1 reference

12 December 2020

Pathology vs. molecular genetics: (re)defining the spectrum of Alport syndrome

1 reference

12 December 2020

Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate

1 reference

12 December 2020

Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice

1 reference

12 December 2020

ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A.

1 reference

12 December 2020

Targeting BMP signalling in cardiovascular disease and anaemia

1 reference

12 December 2020

Inhibition of Activin Signaling Slows Progression of Polycystic Kidney Disease.

1 reference

12 December 2020

TGF-β: the master regulator of fibrosis

1 reference

12 December 2020

No longer going to waste

1 reference

12 December 2020

Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease

1 reference

12 December 2020

Adventitial MSC-like Cells Are Progenitors of Vascular Smooth Muscle Cells and Drive Vascular Calcification in Chronic Kidney Disease

1 reference

12 December 2020

Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease

1 reference

12 December 2020

Runx2 Deletion in Smooth muscle Cells Inhibits Vascular Osteochondrogenesis and Calcification but not Atherosclerotic Lesion Formation.

1 reference

12 December 2020

Absolute Rates of Heart Failure, Coronary Heart Disease, and Stroke in Chronic Kidney Disease: An Analysis of 3 Community-Based Cohort Studies

1 reference

12 December 2020

Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein

1 reference

12 December 2020

Bone histology in incipient and advanced renal failure

1 reference

12 December 2020

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study

1 reference

12 December 2020

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

1 reference

12 December 2020

10.1016/J.KINT.2017.06.016

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28843411 AND SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28843411 AND SRC:MED&resulttype=core&format=json

28 March 2020

PubMed publication ID

28843411

1 reference